OSF Improves the Distributed Pharmaceutical Analysis Lab (DPAL) Margaret Berta
Substandard Pharmaceuticals -substandard pharmaceuticals are medications with >90% of stated API -widespread problem in developing countries -estimated that >30% of pharmaceuticals sold in developing countries are falsified or substandard -often medical regulatory agencies do not have the resources to maintain post-market quality control -graphic showing the number of substandard pharmaceutical cases reported from 2007-2012 Johnston, A., & Holt, D. (2014, Aug). Substandard Drugs: a Potential Crisis for Public Health. Br. J. Clin. Pharmacol., 78(8), 218-243.
Effective Pharmaceutical Regulation -adequate funding -trained personnel -analytical resources -governmental support (Medical Regulatory Authority) (MRA)
Distributed Pharmaceutical Analysis Lab (DPAL)
Program Set-Up Considerations -data security -communication -data sharing -user experience
OSF Registrations for Data Preservation Data Security OSF Registrations for Data Preservation OSF Registrations Non-editable Version Citable Reference Alternative Backup -individual pages but with data submission forms -forms spreadsheet
Internal “peer review” to maintain quality Communication Internal “peer review” to maintain quality DPAL Project Read-Only -individual pages but with data submission forms -forms spreadsheet
Institutional data with controlled results submission Data Sharing Institutional data with controlled results submission Cumulative Results Restricted Access Forms View-Only Spreadsheets Institution Component -individual pages but with data submission forms -forms spreadsheet
HPLC Methodology Manual Usability Informational resources for target audiences HPLC Methodology Manual Students Instructors -individual pages but with data submission forms -forms spreadsheet
DPAL System Set-Up on OSF Application by Participants Assessment DPAL System Set-Up on OSF Application by Participants -system structure but for effective project, we need everyone to actually use it
Questions?